These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
701 related articles for article (PubMed ID: 19147233)
1. Gentamicin-attenuated Leishmania infantum: a clinicopathological study in dogs. Daneshvar H; Molaei MM; Afshar RM; Kamiabi H; Burchmore R; Hagan P; Phillips RS Vet Immunol Immunopathol; 2009 May; 129(1-2):28-35. PubMed ID: 19147233 [TBL] [Abstract][Full Text] [Related]
2. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis. Daneshvar H; Molaei MM; Kamiabi H; Burchmore R; Hagan P; Stephen Phillips R Parasite Immunol; 2010; 32(11-12):722-30. PubMed ID: 21039612 [TBL] [Abstract][Full Text] [Related]
3. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum. Rosypal AC; Zajac AM; Troy GC; Lindsay DS Vet Parasitol; 2005 Jun; 130(1-2):19-27. PubMed ID: 15893066 [TBL] [Abstract][Full Text] [Related]
4. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731 [TBL] [Abstract][Full Text] [Related]
5. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339 [TBL] [Abstract][Full Text] [Related]
6. Dogs vaccinated with gentamicin-attenuated Leishmania infantum or infected with wild-type parasite can be distinguished by Western blotting. Daneshvar H; Mahmmodi Z; Kamiabi H; Phillips RS; Burchmore R Parasite Immunol; 2014 May; 36(5):218-24. PubMed ID: 24611833 [TBL] [Abstract][Full Text] [Related]
7. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs. de Andrade RA; Reis AB; Gontijo CM; Braga LB; Rocha RD; Araújo MS; Vianna LR; Martins-Filho OA Vet Immunol Immunopathol; 2007 Mar; 116(1-2):85-97. PubMed ID: 17287029 [TBL] [Abstract][Full Text] [Related]
8. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals. Gradoni L; Foglia Manzillo V; Pagano A; Piantedosi D; De Luna R; Gramiccia M; Scalone A; Di Muccio T; Oliva G Vaccine; 2005 Nov; 23(45):5245-51. PubMed ID: 16054272 [TBL] [Abstract][Full Text] [Related]
9. Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice. Rafati S; Zahedifard F; Azari MK; Taslimi Y; Taheri T Exp Parasitol; 2008 Mar; 118(3):393-401. PubMed ID: 18093586 [TBL] [Abstract][Full Text] [Related]
10. Alteration in mononuclear cell subpopulations in dogs immunized with gentamicin-attenuated Leishmania infantum. Daneshvar H; Sedghy F; Dabiri S; Kamiabi H; Molaei MM; Phillips S; Burchmore R Parasitology; 2012 Nov; 139(13):1689-96. PubMed ID: 23036240 [TBL] [Abstract][Full Text] [Related]
11. The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection. Carcelén J; Iniesta V; Fernández-Cotrina J; Serrano F; Parejo JC; Corraliza I; Gallardo-Soler A; Marañón F; Soto M; Alonso C; Gómez-Nieto C Vaccine; 2009 Oct; 27(43):5964-73. PubMed ID: 19666153 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant guided polarization of the immune humoral response against a protective multicomponent antigenic protein (Q) from Leishmania infantum. A CpG + Q mix protects Balb/c mice from infection. Parody N; Soto M; Requena JM; Alonso C Parasite Immunol; 2004; 26(6-7):283-93. PubMed ID: 15541032 [TBL] [Abstract][Full Text] [Related]
13. A long term experimental study of canine visceral leishmaniasis. Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J Int J Parasitol; 2007 May; 37(6):683-93. PubMed ID: 17239885 [TBL] [Abstract][Full Text] [Related]
14. Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs. Poot J; Rogers ME; Bates PA; Vermeulen A Vet Parasitol; 2005 Jun; 130(1-2):41-53. PubMed ID: 15893068 [TBL] [Abstract][Full Text] [Related]
16. Canine visceral leishmaniasis: asymptomatic infected dogs as a source of L. infantum infection. Moshfe A; Mohebali M; Edrissian G; Zarei Z; Akhoundi B; Kazemi B; Jamshidi S; Mahmoodi M Acta Trop; 2009 Nov; 112(2):101-5. PubMed ID: 19595664 [TBL] [Abstract][Full Text] [Related]
17. Gentamicin-attenuated Leishmania infantum vaccine: protection of dogs against canine visceral leishmaniosis in endemic area of southeast of Iran. Daneshvar H; Namazi MJ; Kamiabi H; Burchmore R; Cleaveland S; Phillips S PLoS Negl Trop Dis; 2014 Apr; 8(4):e2757. PubMed ID: 24743691 [TBL] [Abstract][Full Text] [Related]
18. [Interpretation of laboratory data during cryptic leishmaniasis in dog]. Gravino AE Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723 [TBL] [Abstract][Full Text] [Related]
19. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. Molano I; Alonso MG; Mirón C; Redondo E; Requena JM; Soto M; Nieto CG; Alonso C Vet Immunol Immunopathol; 2003 Mar; 92(1-2):1-13. PubMed ID: 12628759 [TBL] [Abstract][Full Text] [Related]
20. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice. Daneshvar H; Hagan P; Phillips RS Parasite Immunol; 2003; 25(11-12):589-96. PubMed ID: 15053780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]